Bank & Trust Company’s Bristol-Myers Squibb BMY Stock Holding History

Bank & Trust Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.17M	Buy	20,387 +207	+1%	+$11.9K	0.74%	39
2026 Q1	$1.22M	Sell	20,180 -90	-0.4%	-$5.25K	0.82%	36
2025 Q4	$1.09M	Hold	20,270	–	–	0.77%	36
2025 Q3	$914K	Sell	20,270 -88	-0.4%	-$4.11K	0.68%	44
2025 Q2	$942K	Hold	20,358	–	–	0.75%	43
2025 Q1	$1.24M	Sell	20,358 -304	-1%	-$17.7K	1.01%	30
2024 Q4	$1.17M	Sell	20,662 -728	-3%	-$40.7K	0.98%	30
2024 Q3	$1.11M	Hold	21,390	–	–	0.9%	31
2024 Q2	$888K	Buy	+21,390	New	+$957K	0.75%	36

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Bank & Trust Company's BMY Position: Q2 2026 in Review

Bank & Trust Company increased its Bristol-Myers Squibb (BMY) stake by 1% in Q2 2026, buying an estimated $11.9K and bringing the position to 20,387 shares worth $1.17M. The position accounts for 0.74% of the portfolio, ranked #39.

Bank & Trust Company first reported a position in BMY in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.24M in Q1 2025. 889 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Bank & Trust Company held 20,387 shares of Bristol-Myers Squibb worth $1.17M as of Q2 2026.
Bank & Trust Company bought 207 Bristol-Myers Squibb shares in Q2 2026, an estimated $11.9K.
Bristol-Myers Squibb made up 0.74% of Bank & Trust Company's portfolio in Q2 2026, its #39 holding.
Bank & Trust Company first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 9 quarters since.
Bank & Trust Company's Bristol-Myers Squibb position peaked at $1.24M in Q1 2025.
889 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Bank & Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.